Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0416 per EA under NDC 70010011805. Its NADAC has been published 253 times since Mar 10, 2021.
Strength
400 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010011805
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
12/17/2025
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA075360On Market Since
9/7/2020
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 253 times since Mar 10, 2021, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0416 per EA |
|---|---|
| All-time high | $0.0743 (Jun 16, 2021) |
| All-time low | $0.0399 (Nov 20, 2024) |
| 52-week high | $0.0445 |
| 52-week low | $0.0416 |
| Median price | $0.0556 |
| Average price | $0.0551 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 253 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0416 per EA (NDC 70010011805), effective Jan 7, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 34.5%. It has been tracked across 253 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Mar 10, 2021, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0399 (Nov 20, 2024) to a high of $0.0743 (Jun 16, 2021), with a median of $0.0556 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 400 MG CAPSULE, is $0.0410 per EA — about 1% below GABAPENTIN 400 MG CAPSULE.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 70010011805) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification